Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 27, 2023. (Total: 221476Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 20 (of 20 Records)

Query Trace: Osteosarcoma and ERCC1[original query]
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
The pharmacogenomics journal 2009 Oct 9 (5): 347-53.
Caronia D, Patiño-García A, Milne R L, Zalacain-Díez M, Pita G, Alonso M R, Moreno L T, Sierrasesumaga-Ariznabarreta L, Benítez J, González-Neira
Association of four ERCC1 and ERCC2 SNPs with survival of bone tumour patients.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (8): 3821-4.
Hao Ting, Feng Wei, Zhang Jie, Sun Yong-Jian, Wang Ga
Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (11): 5883-6.
Yang Li-Min, Li Xiu-Hua, Bao Cui-F
ERCC polymorphisms and prognosis of patients with osteosarcoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Oct 35 (10): 10129-36.
Li Jinsong, Liu Shaohua, Wang Weiguo, Zhang Kexiang, Liu Zhendong, Zhang Chaoyue, Chen Shijie, Wu So
Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.
Genetics and molecular research : GMR 2015 14 (3): 10145-51.
Cao Z H, Yin H P, Jiang N, Yu
Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma.
International journal of clinical and experimental pathology 2015 8 (7): 7905-12.
Sun Yongjian, Wu Yi, Li Weicheng, Kong Zhen, Zou Xiaomi
Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
Genetics and molecular research : GMR 2015 14 (3): 11235-41.
Zhang Q, Lv L Y, Li B J, Zhang J, Wei
Single nucleotide polymorphisms of nucleotide excision repair and homologous recombination repair pathways and their role in the risk of osteosarcoma.
Pakistan journal of medical sciences 0 31 (2): 269-73.
Jin Guojun, Wang Min, Chen Weida, Shi Wei, Yin Jiapeng, Gang Wa
Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer.
Oncology letters 2015 Apr 9 (4): 1657-1661.
Gómez-Díaz Benjamín, DE LA Luz Ayala-Madrigal María, Gutiérrez-Angulo Melva, Valle-Solis Aura Erazo, Linares-González Luis Miguel, González-Guzmán Roberto, Cruz-Guillén David, Cedeño-Garcidueñas Ana Lilia, Canto Patricia, López-Hernández Luz Bereni
Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
International journal of clinical and experimental pathology 2015 8 (1): 894-9.
Ji Wei-Ping, He Neng-B
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Genetics and molecular research : GMR 2015 14 (3): 11652-7.
Wang M J, Zhu Y, Guo X J, Tian Z
Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.
Cancer epidemiology 2015 Apr 39 (2): 182-8.
Gori?ar Katja, Kova? Viljem, Jazbec Janez, Zakotnik Branko, Lamovec Janez, Dolžan Vi
Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
World journal of surgical oncology 2017 Apr 15 (1): 75.
Zhang Haiguang, Ge Junbo, Hong Huanyu, Bi Lili, Sun Zhengw
Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis.
Oncotarget 2017 Sep 8 (37): 62769-62779.
Liu Xueyong, Zhang Zhan, Deng Chunbo, Tian Yihao, Ma X
The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
BMC medical genetics 2018 Jul 19 (1): 112.
Obiedat Hadeel, Alrabadi Nasr, Sultan Eyad, Al Shatti Marwa, Zihlif Mal
Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis.
OncoTargets and therapy 2018 11 3495-3504.
Li Chunpu, Yu Xin, Guo Dongmei, Liu Guanhua, Zhang Kaigang, Teng Qingliang, Lin H
Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
Medicine 2018 Dec 97 (49): e13358.
Liu Dabiao, Liu Xueso
ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
European review for medical and pharmacological sciences 2018 Oct 22 (20): 6658-6666.
Chen X-J, Tong Z-C, Kang X, Wang Z-C, Huang G-L, Yang T-M, Dong
Association of ERCC gene polymorphism with osteosarcoma risk.
African health sciences 2020 Dec 20 (4): 1840-1848.
Wang Guanliang, Li Jianping, Xu Xiling, Gupta Ramit Kumar, Gao Xiaoqia
Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
International journal of molecular sciences 2022 Oct 23 (19): .
Hattinger Claudia Maria, Casotti Chiara, Patrizio Maria Pia, Luppi Silvia, Fantoni Leonardo, Scotlandi Katia, Ibrahim Toni, Serra Massi
TOP